Dr. Gordon Amidon

1. Incecayir, Tuba, et al. "Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue."Journal of pharmaceutical sciences 105.2 (2016): 925-934.
2. Cao, Fengjuan, et al. "Mechanistic Analysis of Cocrystal Dissolution as a Function of pH and Micellar Solubilization." Molecular pharmaceutics 13.3 (2016): 1030-1046.
3. Talattof, Arjang, Judy C. Price, and Gordon L. Amidon. "Gastrointestinal Motility Variation and Implications for Plasma Level Variation: Oral Drug Products." Molecular pharmaceutics 13.2 (2016): 557-567.
4. Matsui, Kazuki, et al. "The Evaluation of In Vitro Drug Dissolution of Commercially Available Oral Dosage Forms for Itraconazole in Gastrointestinal Simulator With Biorelevant Media." Journal of pharmaceutical sciences (2016).
5. Sheng, Jennifer J., and Gordon L. Amidon. "8 The Biopharmaceutics Classification System: Recent Applications in Pharmaceutical Discovery, Development, and Regulation." Oral Drug Absorption (2016): 138.

Dr. Marival Bermejo

1. Casañola-Martin, Gerardo, et al. "Exploring different strategies for imbalanced ADME data problem: case study on Caco-2 permeability modeling." Molecular diversity 20.1 (2016): 93-109.

Dr. Jack A. Cook

1. Younis, Islam R., et al. "Utility of Model Based Approaches for Informing Dosing Recommendations in Specific Populations: Report from the Public AAPS Workshop." The Journal of Clinical Pharmacology (2016).

Dr. Peter Langgut

1. Brüll, Verena, et al. "Acute intake of quercetin from onion skin extract does not influence postprandial blood pressure and endothelial function in overweight-to-obese adults with hypertension: a randomized, double-blind, placebo-controlled, crossover trial." European journal of nutrition (2016): 1-11.
2. Kranz, Lena M., et al. "Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy." Nature (2016).
3. Jabulowsky, Robert A., et al. "Abstract B041: A novel nanoparticular formulated tetravalent RNA cancer vaccine for treatment of patients with malignant melanoma." Cancer Immunology Research 4.1 Supplement (2016): B041-B041.
4. Knopp, Matthias Manne, et al. "Influence of polymer molecular weight on in vitro dissolution behavior and in vivo performance of celecoxib: PVP amorphous solid dispersions." European Journal of Pharmaceutics and Biopharmaceutics 101 (2016): 145-151.
5. Knopp, Matthias Manne, et al. "Influence of Copolymer Composition on In Vitro and In Vivo Performance of Celecoxib-PVP/VA Amorphous Solid Dispersions." The AAPS journal 18.2 (2016): 416-423.
6. Knopp, Matthias Manne, et al. "Effect of polymer type and drug dose on the in vitro and in vivo behavior of amorphous solid dispersions." European Journal of Pharmaceutics and Biopharmaceutics (2016).
7. Knopp, Matthias Manne, et al. "A promising new method to estimate drug-polymer solubility at room temperature." Journal of pharmaceutical sciences (2016).
8. Goodarzi, Navid, et al. "Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Ribavirin." Journal of pharmaceutical sciences 105.4 (2016): 1362-1369.
9. Al-Gousous, Jozef, and Peter Langguth. "Effect of Calcium Ions on the Disintegration of Enteric-Coated Solid Dosage Forms." Journal of pharmaceutical sciences 105.2 (2016): 509-511.
10. Gogoll, Karsten, et al. "Solid Nanoemulsion as Antigen and Immunopotentiator Carrier for Transcutaneous Immunization." Cellular Immunology (2016).

Dr. Hans Lennernä

1. Johannsson, Gudmundur, et al. "Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study." European Journal of Endocrinology 175.1 (2016): 85-93.

Dr. James Poll

1. Li, Qing, et al. "Effect of Ondansetron on Metformin Pharmacokinetics and Response in Healthy Subjects." Drug Metabolism and Disposition 44.4 (2016): 489-494.
2. Ting, Tricia, et al. "Evaluation of Reproducibility of Pharmacokinetics and Clinical Outcome Differences with Brand and Generic Lamotrigine Switching in Epilepsy Patients (BEEP FU Study)(P2. 033)." Neurology 86.16 Supplement (2016): P2-033.
3. Vaithianathan, Soundarya, et al. "Effect of common excipients on the oral drug absorption of biopharmaceutics classification system class 3 drugs cimetidine and acyclovir." Journal of pharmaceutical sciences 105.2 (2016): 996-1005.
4. Vaithianathan, Soundarya, et al. "Reply to “On the Effect of Common Excipients on the Oral Absorption of Class 3 Drugs”." Journal of pharmaceutical sciences 105.4 (2016): 1355-1357.
5. Goodarzi, Navid, et al. "Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Ribavirin." Journal of pharmaceutical sciences 105.4 (2016): 1362-1369.
6. Stack, Christopher, James Polli, and Tricia Ting. "Pill Color Preference Considerations in Clinical Trial Design (P2. 037)." Neurology 86.16 Supplement (2016): P2-037.
7. Vaithianathan, Soundarya, et al. "Release of levetiracetam from extended-release tablets that appear intact in patient stool." Seizure 40 (2016): 7-9.
8. Polli, James E. "11 BCS: Today and Tomorrow." Oral Drug Absorption(2016): 206.

Dr. Ikumi Tama

1. Incecayir, Tuba, et al. "Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue."Journal of pharmaceutical sciences 105.2 (2016): 925-934.
2. Takeuchi, Ryota, et al. "Local Drug–Drug Interaction of Donepezil with Cilostazol at Breast Cancer Resistance Protein (ABCG2) Increases Drug Accumulation in Heart." Drug Metabolism and Disposition 44.1 (2016): 68-74.
3. Kasai, Taku, et al. "Role of OATP2A1 in PGE 2 secretion from human colorectal cancer cells via exocytosis in response to oxidative stress."Experimental cell research 341.2 (2016): 123-131.
4. Fujita, Daichi, et al. "Organic anion transporting polypeptide (OATP) 2B1 contributes to gastrointestinal toxicity of anticancer drug SN-38, active metabolite of irinotecan hydrochloride." Drug Metabolism and Disposition44.1 (2016): 1-7.
5. Hoshino, Yusuke, et al. "Molecular localization and characterization of multiple binding sites of organic anion transporting polypeptide 2B1 (OATP2B1) as the mechanism for substrate and modulator dependent drug-drug interaction." MedChemComm (2016).
6. Gose, Tomoka, et al. "Prostaglandin transporter (OATP2A1/SLCO2A1) contributes to local disposition of eicosapentaenoic acid-derived PGE 3."Prostaglandins & other lipid mediators 122 (2016): 10-17.
7. Matsunaga, Norikazu, et al. "Analysis of the metabolic pathway of bosentan and of the cytotoxicity of bosentan metabolites based on a quantitative modeling of metabolism and transport in sandwich-cultured human hepatocytes." Drug Metabolism and Disposition 44.1 (2016): 16-27.
8. Saito, Yoshimasa, et al. "A retrospective study of treatment and prophylaxis of ifosfamide-induced hemorrhagic cystitis in pediatric and adolescent and young adult (AYA) patients with solid tumors." Japanese Journal of Clinical Oncology (2016).

Dr. Shinji Yamashit

1. Hisada, Nozomi, et al. "Characterizing the Dissolution Profiles of Supersaturable Salts, Cocrystals, and Solvates to Enhance In Vivo Oral Absorption." European Journal of Pharmaceutics and Biopharmaceutics(2016).
2. Nagai, Mika, et al. "Establishment of in silico prediction models for CYP3A4 and CYP2B6 induction in human hepatocytes by multiple regression analysis using azole compounds." Drug Metabolism and Disposition (2016): dmd-115.
3. Kataoka, Makoto, et al. "Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process." European Journal of Pharmaceutics and Biopharmaceutics 101 (2016): 103-111.
4. Kovacevic, Goran, and Shinji Yamashita. "Waveguide design parameters impact on absorption in graphene coated silicon photonic integrated circuits."Optics express 24.4 (2016): 3584-3591.
5. Higashino, Haruki, et al. "Effect of precipitation/re-dissolution processes from the supersaturated solution on the intestinal absorption of poorly water-soluble drugs." asian journal of pharmaceutical sciences 11.1 (2016): 68-69.
6. Yano, Koji, et al. "Evaluation of dose-dependent oral absorption of a newly developed drug candidate: In vitro-in vivo correlation." Journal of Drug Delivery Science and Technology 31 (2016): 160-166.
7. Miyaji, Yoshihiro, et al. "Advantage of the Dissolution/Permeation system for estimating oral absorption of drug candidates in the drug discovery stage."Molecular pharmaceutics 13.5 (2016): 1564-1574.
8. Yoshimatsu, Hiromichi, et al. "Usefulness of minipigs for predicting human pharmacokinetics: Prediction of distribution volume and plasma clearance."Drug metabolism and pharmacokinetics 31.1 (2016): 73-81.